Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Cyclosporine therapeutic drug monitoring in nephrotic syndrome: which time point to use for a generic product?

  • At: 2011 FIP Congress in Hyderabad (India)
  • Type: Poster
  • By: DU, Xiaoli (Peking Union Medical College Hospital, Beijing, China)
  • Co-author(s): Wang, Haiyun (Peking Union Medical College Hospital, Beijing, China)
    Fu, Qiang (Peking Union Medical College Hospital, Beijing, China)
    Chen, Limeng (Peking Union Medical College Hospital, Beijing, China)
    Li, Xuemei (Peking Union Medical College Hospital, Beijing, China)
    Zhu, Zhu (Peking Union Medical College Hospital, Beijing, China)
  • Abstract:

    Background: C2 monitoring has been accepted for cyclosporine (CsA) TDM in organ transplantation for about 10 years. However, there is limited information on nephrotic syndrome (NS), although CsA is widely used in its treatment. Another issue is whether C2 remains the best choice for generic products. The aim of this study is to investigate the..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses